WS13.02Two children homozygous for the complex allele p.Leu467Phe-p.Phe508del with reduced clinical response to elexacaftor/tezacaftor/ivacaftor but differences in nasal potential difference measurement

IF 5.4 2区 医学 Q1 RESPIRATORY SYSTEM
R. Dalferth , K. Schütz , J. Berger , S.Y. Graeber , A. Balázs , M.A. Mall , F. Stanke , P. Maier , S. Tamm , N. Alfeis , B. Tümmler , A.-M. Dittrich
{"title":"WS13.02Two children homozygous for the complex allele p.Leu467Phe-p.Phe508del with reduced clinical response to elexacaftor/tezacaftor/ivacaftor but differences in nasal potential difference measurement","authors":"R. Dalferth ,&nbsp;K. Schütz ,&nbsp;J. Berger ,&nbsp;S.Y. Graeber ,&nbsp;A. Balázs ,&nbsp;M.A. Mall ,&nbsp;F. Stanke ,&nbsp;P. Maier ,&nbsp;S. Tamm ,&nbsp;N. Alfeis ,&nbsp;B. Tümmler ,&nbsp;A.-M. Dittrich","doi":"10.1016/j.jcf.2025.03.565","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>In vitro studies demonstrate that homozygosity for the complex allele p.Leu467Phe-p.Phe508del (L467F-F508del) is associated with failure to respond to Elexacaftor/Tezacaftor/Ivacaftor (ETI). The functional CFTR response in vivo in homozygous carriers of these mutations has not yet been investigated. We report clinical and functional responses towards ETI of two L467F-F508del homozygous children.</div></div><div><h3>Methods</h3><div>Both received functional assessments of CFTR responses via sweat chloride and nasal potential difference (nPD) measurements along with in vitro testing of responsiveness in primary nasal epithelial cell cultures before and during ETI and one child additionally during lumacaftor/ivacaftor (LUM/IVA) therapy.</div></div><div><h3>Results</h3><div>The diagnosis of CF was made in the 1st and 3rd year of life revealing F508del homozygosity in both cases. After initiation of LUM/IVA, no drop in sweat chloride was observed in either child. The girl was switched to ETI at the age of 11, and the boy at age 6 years. Lack of pronounced drop in sweat chloride after initiation of ETI in both children (- 18mmol/l to 85mmol/l and -15 mmol/l to 93 mmol/l, respectively) led to resequencing of CFTR, which revealed L467F homozygosity in both children. Both showed sub-par clinical responses with the girl experiencing continued decline in lung function and the boy demonstrating an above average number of pulmonary exacerbations. Both children received nPD measurements with and without ETI therapy, which showed discrepant responses. Whereas the boy did not have any activity-differences by nPD, the girl showed a sub-par, but notable response during ETI therapy. In vitro testing in nasal epithelial cell culture is pending.</div></div><div><h3>Conclusion</h3><div>The presence of L467F-F508del homozygosity does not lead uniformly abrogate CFTR's response towards modulation via ETI, but is associated with a significantly reduced response. Therefore further investigation of complex alleles on CFTR modulator responsiveness is important.</div></div>","PeriodicalId":15452,"journal":{"name":"Journal of Cystic Fibrosis","volume":"24 ","pages":"Page S25"},"PeriodicalIF":5.4000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cystic Fibrosis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1569199325006617","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

In vitro studies demonstrate that homozygosity for the complex allele p.Leu467Phe-p.Phe508del (L467F-F508del) is associated with failure to respond to Elexacaftor/Tezacaftor/Ivacaftor (ETI). The functional CFTR response in vivo in homozygous carriers of these mutations has not yet been investigated. We report clinical and functional responses towards ETI of two L467F-F508del homozygous children.

Methods

Both received functional assessments of CFTR responses via sweat chloride and nasal potential difference (nPD) measurements along with in vitro testing of responsiveness in primary nasal epithelial cell cultures before and during ETI and one child additionally during lumacaftor/ivacaftor (LUM/IVA) therapy.

Results

The diagnosis of CF was made in the 1st and 3rd year of life revealing F508del homozygosity in both cases. After initiation of LUM/IVA, no drop in sweat chloride was observed in either child. The girl was switched to ETI at the age of 11, and the boy at age 6 years. Lack of pronounced drop in sweat chloride after initiation of ETI in both children (- 18mmol/l to 85mmol/l and -15 mmol/l to 93 mmol/l, respectively) led to resequencing of CFTR, which revealed L467F homozygosity in both children. Both showed sub-par clinical responses with the girl experiencing continued decline in lung function and the boy demonstrating an above average number of pulmonary exacerbations. Both children received nPD measurements with and without ETI therapy, which showed discrepant responses. Whereas the boy did not have any activity-differences by nPD, the girl showed a sub-par, but notable response during ETI therapy. In vitro testing in nasal epithelial cell culture is pending.

Conclusion

The presence of L467F-F508del homozygosity does not lead uniformly abrogate CFTR's response towards modulation via ETI, but is associated with a significantly reduced response. Therefore further investigation of complex alleles on CFTR modulator responsiveness is important.
两个孩子的复杂等位基因p.l u467php纯合。Phe508del对eleexaftor /tezacaftor/ivacaftor的临床反应降低,但在鼻电位差测量上存在差异
目的体外研究表明,复合等位基因p.l eu467php具有纯合性。Phe508del (L467F-F508del)与Elexacaftor/Tezacaftor/Ivacaftor (ETI)无效相关。这些突变的纯合载体在体内的功能性CFTR反应尚未被研究。我们报告了两名L467F-F508del纯合儿童对ETI的临床和功能反应。方法通过汗液氯化物和鼻电位差(nPD)测量对两名儿童的CFTR反应进行功能评估,并在ETI前和ETI期间对原代鼻上皮细胞培养物进行反应性体外测试,另外在lumacaftor/ivacaftor (LUM/IVA)治疗期间对一名儿童进行反应性体外测试。结果两例患者均在出生后1年和3年诊断为CF,显示F508del纯合性。启动LUM/IVA后,两名儿童的汗液氯化物均未下降。女孩11岁时被转到ETI,男孩6岁时被转到ETI。在开始ETI后,两名儿童的汗液氯化物没有明显下降(分别为- 18mmol/l至85mmol/l和- 15mmol /l至93 mmol/l),导致CFTR重测序,结果显示两名儿童的L467F纯合性。两者均表现出低于标准的临床反应,女孩的肺功能持续下降,男孩的肺恶化次数高于平均水平。两名儿童都接受了有ETI治疗和没有ETI治疗的nPD测量,结果显示出不同的反应。虽然男孩在nPD方面没有任何活动差异,但女孩在ETI治疗期间表现出低于标准但显着的反应。鼻上皮细胞培养的体外试验尚待确定。结论L467F-F508del纯合子的存在并不能完全消除CFTR对ETI调制的响应,但与显著降低的响应相关。因此,进一步研究复杂等位基因对CFTR调制器响应性的影响具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cystic Fibrosis
Journal of Cystic Fibrosis 医学-呼吸系统
CiteScore
10.10
自引率
13.50%
发文量
1361
审稿时长
50 days
期刊介绍: The Journal of Cystic Fibrosis is the official journal of the European Cystic Fibrosis Society. The journal is devoted to promoting the research and treatment of cystic fibrosis. To this end the journal publishes original scientific articles, editorials, case reports, short communications and other information relevant to cystic fibrosis. The journal also publishes news and articles concerning the activities and policies of the ECFS as well as those of other societies related the ECFS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信